Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Update on the antiretroviral activity of 873140

March 1, 2005

CMPD-167 protects macaques from vaginal SHIV transmission

March 1, 2005

Update on the antiretroviral efficacy of TMC-278 in HIV infection

Feb. 28, 2005

PRO-2000/5 gel retains antiviral efficacy for up to one hour after intravaginal application

Feb. 28, 2005

L-000870810 reported to reduce viral load in HIV-infected patients

Feb. 28, 2005

TH-9507 improves quality of life of HIV-infected patients with abdominal fat accumulation

Feb. 28, 2005

TAK-652 shows potent in vitro anti-HIV-1 activity and a safe profile in humans

Feb. 28, 2005

UIC-02031 blocks replication of primary and multidrug-resistant HIV variants

Feb. 28, 2005

First phase I data on the effects and safety of the HIV vaccine tgAAC-09

Feb. 28, 2005

Add-on capravirine enhances the efficacy of a standard-of-care antiretroviral regimen

Feb. 25, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...